Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Champions Oncology NASDAQ CSBR
$5.02 -0.04 -0.80%
Today share price
USA
Sector: Healthcare Industry: Life Sciences Tools & Services
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 26 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

68.24M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
59.33M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.13
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
13.59M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-10.67 %
Upcoming events Champions Oncology All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Champions Oncology

Stock analysis Champions Oncology

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-7.01 27.67
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
14.72 5.21
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-9.85 22.73
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.48 0.47
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
472.69 13.20

Price change Champions Oncology per year

8.30$ 14.68$
Min Max

Summary analysis Champions Oncology

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Champions Oncology

Revenue and net income Champions Oncology

All parameters
Stock news Champions Oncology All news

About company Champions Oncology

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Address:
One University Plaza, Hackensack, NJ, United States, 07601
Company name: Champions Oncology
Issuer ticker: CSBR
ISIN: US15870P3073
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2003-01-10
Sector: Healthcare
Industry: Life Sciences Tools & Services
Site: https://www.championsoncology.com

On which stock exchange are Champions Oncology (CSBR) stocks traded?

Champions Oncology (CSBR) stocks are traded on NASDAQ.

What is the ticker of Champions Oncology stocks (CSBR)?

The stock ticker of Champions Oncology’s stocks or in other words, the code is CSBR. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Champions Oncology (CSBR) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Champions Oncology (CSBR) belongs to the «Healthcare» sector and the «Life Sciences Tools & Services» industry.

In what currency are Champions Oncology (CSBR) stocks traded?

Champions Oncology (CSBR) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Champions Oncology (CSBR) stocks today?

The current price of Champions Oncology stocks on 29.04.2024 is 5.02 dollars. per share.

What is the dynamics of Champions Oncology (CSBR) stocks from the beginning of the year?

Champions Oncology (CSBR) quotes have increased by -13.3% from the beginning of the year up to 5.02 dollars. per 1 stocks.

How much did Champions Oncology (CSBR) stocks increase in апреле 2024?

This month Champions Oncology (CSBR) quotes have increased by 2.24% to 5.02 dollars. per share.

How much are Champions Oncology (CSBR) stocks worth?

Today, on October, 29.04.2024 Champions Oncology’s (CSBR) stocks cost 5.02 dollars..

What is the market capitalization of Champions Oncology (CSBR)?

Capitalization is the market value of Champions Oncology (CSBR) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Champions Oncology (CSBR) is estimated at about 68240665 dollars.